Site-specific PEGylation enhances the pharmacokinetic properties and anti-tumor activity of Interferon Beta-1b.
Lee JI, Eisenberg SP, Rosendahl MS, Chlipala EA, Brown JD, Doherty DH, Cox GN.
Journal of Interferon and Cytokine Research 33: 769-777, 2013.